Udo C. T. Oppermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Udo C. T. Oppermann has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Hans Jörnvall
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden
8 shared publicationsCharlotta Filling
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden
5 shared publicationsErik Nordling
Biovitrum AB, SE-112 87 Stockholm, Sweden
4 shared publications- Bengt Persson
Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
3 shared publications Edmund Maser
3 shared publicationsNaeem Shafqat
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden
3 shared publications
Latest Publications
- 1 April 2004
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 61 (7-8) , 992-999
Human and rodent type 1 11 -hydroxysteroid dehydrogenases are 7 -hydroxycholesterol dehydrogenases involved in oxysterol metabolism
Interconversion between cortisone and the glucocorticoid receptor ligand cortisol is carried out by 11β-hydroxysteroid dehydrogenase (11β-HSD)isozymes and constitutes a medically important example of pre-receptor control of steroid hormones. The enzyme 11β-HSD type 1 (11β-HSD1) catalyzes the conversion of cortisone to its active receptor-binding derivative cortisol, whereas 11β-HSD type 2 performs the reverse reaction. Specific inhibitors against the type 1 enzyme lower intracellular levels of glucocorticoid hormone, with an important clinical application in insulin resistance and other metabolic disorders. We report here on the in vitro oxysterol-metabolizing properties of human and rodent 11β-HSD1. The enzyme, either as full-length, membrane-attached, or as a transmembrane domain-deleted, soluble form, mediates exclusively conversion between 7-ketocholesterol and 7β-hydroxycholesterol with similar kcat values as observed with glucocorticoid hormones. Thus, human, rat, and mouse 11β-HSD1 have dual enzyme activities like the recently described 7α-hydroxysteroid dehydrogenase/11β-hydroxysteroid dehydrogenase from hamster liver, but differ fundamentally from the latter in that 7β-OH rather than 7α-OH dehydrogenase constitutes the second activity. These results demonstrate an enzymatic origin of species differences in 7-oxysterol metabolism, establish the origin of endogenous 7β-OH cholesterol in humans, and point to a possible involvement of 11β-HSD1 in atherosclerosis.
- 1 April 2004
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 61 (7-8) , 992-999
Human and rodent type 1 11 -hydroxysteroid dehydrogenases are 7 -hydroxycholesterol dehydrogenases involved in oxysterol metabolism
Interconversion between cortisone and the glucocorticoid receptor ligand cortisol is carried out by 11β-hydroxysteroid dehydrogenase (11β-HSD)isozymes and constitutes a medically important example of pre-receptor control of steroid hormones. The enzyme 11β-HSD type 1 (11β-HSD1) catalyzes the conversion of cortisone to its active receptor-binding derivative cortisol, whereas 11β-HSD type 2 performs the reverse reaction. Specific inhibitors against the type 1 enzyme lower intracellular levels of glucocorticoid hormone, with an important clinical application in insulin resistance and other metabolic disorders. We report here on the in vitro oxysterol-metabolizing properties of human and rodent 11β-HSD1. The enzyme, either as full-length, membrane-attached, or as a transmembrane domain-deleted, soluble form, mediates exclusively conversion between 7-ketocholesterol and 7β-hydroxycholesterol with similar kcat values as observed with glucocorticoid hormones. Thus, human, rat, and mouse 11β-HSD1 have dual enzyme activities like the recently described 7α-hydroxysteroid dehydrogenase/11β-hydroxysteroid dehydrogenase from hamster liver, but differ fundamentally from the latter in that 7β-OH rather than 7α-OH dehydrogenase constitutes the second activity. These results demonstrate an enzymatic origin of species differences in 7-oxysterol metabolism, establish the origin of endogenous 7β-OH cholesterol in humans, and point to a possible involvement of 11β-HSD1 in atherosclerosis.
- 15 November 2003
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 376 (1) , 49-60
Expanded substrate screenings of human and Drosophila type 10 17β-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3α/7α/7β/17β/20β/21-HSD
17β-Hydroxysteroid dehydrogenases (17β-HSDs) catalyse the conversion of 17β-OH (-hydroxy)/17-oxo groups of steroids, and are essential in mammalian hormone physiology. At present, eleven 17β-HSD isoforms have been defined in mammals, with different tissue-expression and substrate-conversion patterns. We analysed 17β-HSD type 10 (17β-HSD10) from humans and Drosophila, the latter known to be essential in development. In addition to the known hydroxyacyl-CoA dehydrogenase, and 3α-OH and 17β-OH activities with sex steroids, we here demonstrate novel activities of 17β-HSD10. Both species variants oxidize the 20β-OH and 21-OH groups in C21 steroids, and act as 7β-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid (also known as 7β-hydroxylithocholic acid or 7β-hydroxyisolithocholic acid respectively). Additionally, the human orthologue oxidizes the 7α-OH of chenodeoxycholic acid (5β-cholanic acid, 3α,7α-diol) and cholic acid (5β-cholanic acid). These novel substrate specificities are explained by homology models based on the orthologous rat crystal structure, showing a wide hydrophobic cleft, capable of accommodating steroids in different orientations. These properties suggest that the human enzyme is involved in glucocorticoid and gestagen catabolism, and participates in bile acid isomerization. Confocal microscopy and electron microscopy studies reveal that the human form is localized to mitochondria, whereas Drosophila 17β-HSD10 shows a cytosolic localization pattern, possibly due to an N-terminal sequence difference that in human 17β-HSD10 constitutes a mitochondrial targeting signal, extending into the Rossmann-fold motif.
- 15 November 2003
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 376 (1) , 49-60
Expanded substrate screenings of human and Drosophila type 10 17β-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3α/7α/7β/17β/20β/21-HSD
17β-Hydroxysteroid dehydrogenases (17β-HSDs) catalyse the conversion of 17β-OH (-hydroxy)/17-oxo groups of steroids, and are essential in mammalian hormone physiology. At present, eleven 17β-HSD isoforms have been defined in mammals, with different tissue-expression and substrate-conversion patterns. We analysed 17β-HSD type 10 (17β-HSD10) from humans and Drosophila, the latter known to be essential in development. In addition to the known hydroxyacyl-CoA dehydrogenase, and 3α-OH and 17β-OH activities with sex steroids, we here demonstrate novel activities of 17β-HSD10. Both species variants oxidize the 20β-OH and 21-OH groups in C21 steroids, and act as 7β-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid (also known as 7β-hydroxylithocholic acid or 7β-hydroxyisolithocholic acid respectively). Additionally, the human orthologue oxidizes the 7α-OH of chenodeoxycholic acid (5β-cholanic acid, 3α,7α-diol) and cholic acid (5β-cholanic acid). These novel substrate specificities are explained by homology models based on the orthologous rat crystal structure, showing a wide hydrophobic cleft, capable of accommodating steroids in different orientations. These properties suggest that the human enzyme is involved in glucocorticoid and gestagen catabolism, and participates in bile acid isomerization. Confocal microscopy and electron microscopy studies reveal that the human form is localized to mitochondria, whereas Drosophila 17β-HSD10 shows a cytosolic localization pattern, possibly due to an N-terminal sequence difference that in human 17β-HSD10 constitutes a mitochondrial targeting signal, extending into the Rossmann-fold motif.
- Top Cited Papers
- 1 February 2003
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 143-144, 247-253
Short-chain dehydrogenases/reductases (SDR): the 2002 update
- 1 February 2003
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 143-144, 247-253
Top Cited PapersShort-chain dehydrogenases/reductases (SDR): the 2002 update
- Open Access
- 1 January 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (3) , 2030-2035
Comparative Enzymology of 11β-Hydroxysteroid Dehydrogenase Type 1 from Glucocorticoid Resistant (Guinea Pig) Versus Sensitive (Human) Species
- 1 January 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (3) , 2030-2035
Open AccessComparative Enzymology of 11β-Hydroxysteroid Dehydrogenase Type 1 from Glucocorticoid Resistant (Guinea Pig) Versus Sensitive (Human) Species
- Top Cited PapersOpen Access
- 1 July 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (28) , 25677-25684
Critical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases
- 1 July 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (28) , 25677-25684
Top Cited PapersOpen AccessCritical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases
- 1 December 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (3) , 712-717
Structural Role of Conserved Asn179 in the Short-Chain Dehydrogenase/Reductase Scaffold
- 1 December 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (3) , 712-717
Structural Role of Conserved Asn179 in the Short-Chain Dehydrogenase/Reductase Scaffold
- 29 August 2001
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 19 (6) , 514-520
Human type 10 17β-hydroxysteroid dehydrogenase: molecular modelling and substrate docking
- 29 August 2001
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 19 (6) , 514-520
Human type 10 17β-hydroxysteroid dehydrogenase: molecular modelling and substrate docking
- Open Access
- 1 August 2001
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (15) , 4113-4125
Metabolic conversion as a pre‐receptor control mechanism for lipophilic hormones
The majority of physiological effects mediated by steroids, retinoids and thyroids is accomplished by binding to members of the nuclear receptor superfamily of ligand activated transcription factors....
- 1 August 2001
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (15) , 4113-4125
Open AccessMetabolic conversion as a pre‐receptor control mechanism for lipophilic hormones
The majority of physiological effects mediated by steroids, retinoids and thyroids is accomplished by binding to members of the nuclear receptor superfamily of ligand activated transcription factors....
- 1 January 2001
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 130-132, 699-705
Forms and functions of human SDR enzymes
- 1 January 2001
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 130-132, 699-705
Forms and functions of human SDR enzymes
- 3 April 2000
- Published by Elsevier in Toxicology
- Vol. 144 (1-3) , 163-168
Lack of quinone reductase activity suggests that amyloid-β peptide/ERAB induced lipid peroxidation is not directly related to production of reactive oxygen species by redoxcycling
- 3 April 2000
- Published by Elsevier in Toxicology
- Vol. 144 (1-3) , 163-168
Lack of quinone reductase activity suggests that amyloid-β peptide/ERAB induced lipid peroxidation is not directly related to production of reactive oxygen species by redoxcycling